ERBB2 and neoplasm: As evident from a co-immunoprecipitation (co-IP) analysis of the dissected tumor xenografts (Fig. 2b), and from a proximity ligation assay (PLA), performed on SKBR3 and MDCK cells (Fig. 3a and S1A, respectively), GroA significantly reduced ErbB2 binding by nucleolin.